ESMO 2026 has ended. This guide stays up as the record of who was there. Next: ESMO 2027, Sep 17–21, 2027 in Barcelona

Barts Cancer Institute, Queen Mary University of London at ESMO 2026

Oct 23–27, 2026 Madrid, Spain ~37k attendees Website

Barts Cancer Institute, Queen Mary University of London takes part in 9 sessions at ESMO 2026 in Madrid. Its sessions explore biomarkers and treatment response in breast cancer and melanoma, alongside bladder cancer research. They examine how artificial intelligence applied to tissue images may distinguish groups within HER2-positive breast cancer.

OrganizationESMO 2026 Attendance
University & institute
Cancer research institute of Queen Mary University of London, in London, United Kingdom, and part of a Cancer Research UK centre.
Poster
Fri Oct 23
15:15–16:00
Deciphering host immunotherapy response and immune-related toxicities through longitudinal multimodal liquid biopsy analysis in advanced melanoma
Friday Poster Display session 4
Melanoma & skin cancersBiomarkers & precision oncology
Poster
Fri Oct 23
15:15–16:00
Enhancing quantification of tumour burden in response to immunotherapy through longitudinal multimodal ctDNA analysis in advanced melanoma
Friday Poster Display session 1
Melanoma & skin cancersBiomarkers & precision oncology
Poster
Sat Oct 24
12:00–12:45
H&E-based AI stratifies clinically HER2-positive breast cancer, identifying a luminal subgroup with reduced therapy receipt and worse survival
Saturday Poster Display session 2
Breast cancerBiomarkers & precision oncology
Poster
Sat Oct 24
12:00–12:45
HER2 downstream signalling activity stratifies response to neoadjuvant HER2-targeted therapy in I-SPY2
Saturday Poster Display session 2
Breast cancerBiomarkers & precision oncology
Satellite
Sat Oct 24
13:35–13:55
Navigating an evolving treatment paradigm in 1L mTNBC
AstraZeneca - Advancing 1L Breast Cancer Care Across Subtypes: Recent Developments and Future Directions
Breast cancer
Abstract
Sat Oct 24
16:54–17:06
Chair
Sun Oct 25
08:30–10:00
Rapid oral 1: Basic science and translational research
with University of Luxembourg, Clínica Universidad de Navarra
Biomarkers & precision oncology
Abstract
Sun Oct 25
08:40–08:52
Invited Discussant 4244RO and 4245RO
Rapid oral 1: Basic science and translational research
Biomarkers & precision oncology
Poster
Sun Oct 25
12:00–12:45
Chair
Sun Oct 25
14:45–15:45

Explore the full ESMO 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Madrid. Leave your work email and we’ll be in touch.

Privacy

Download the full ESMO 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Barts Cancer Institute, Queen Mary University of London

Tell us what you sell and we’ll find the people at Barts Cancer Institute, Queen Mary University of London most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction